Alnylam Pharmaceuticals (ALNY) Q1 2025 Earnings

13FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.12
-0.79
-0.46
-0.13

Details

Expected EPS
-0.592096
Actual EPS
-0.65
Surprise EPS
-0.06
Surprise Percent
+9.78%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.65 per share for Q1 2025.

0 Comments

Share your thoughts